Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-516 Inj. Administered on A Twice-Weekly Schedule in Patients With Advanced Solid Cancers Failed to Standard Therapy

Trial Profile

Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-516 Inj. Administered on A Twice-Weekly Schedule in Patients With Advanced Solid Cancers Failed to Standard Therapy

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs CKD 516 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 20 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 29 Aug 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea, KCT0000499).
    • 25 Jul 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top